COVID-19-associated mucormycosis and treatments

Vetriselvan Subramaniyan¹, Shivkanya Fuloria², Hari Kumar Darnal³, Dhanalekshmi Unnikrishnan Meenakshi⁴, Mahendran Sekar⁵, Rusli Bin Nordin¹, Srikumar Chakravarthi¹, Kathiresan V Sathasivam⁶, Shah Alam Khan⁴, Yuan Seng Wu⁷, Usha Kumari⁸, Kalvatala Sudhakar⁹, Rishabha Malviya¹⁰, Vipin Kumar Sharma¹¹, Neeraj Kumar Fuloria^2
1 Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jalan SP 2, Bandar Saujana Putra, 42610 Jenjarom Selangor, Malaysia
² Faculty of Pharmacy & Centre of Excellence for Biomaterials Engineering, AIMST University, Bedong 08100, Kedah, Malaysia
³ Jeffrey Cheah School of Medicine & Health Sciences, Monash University, Selangor 47500, Malaysia
⁴ College of Pharmacy, National University of Science and Technology, 130 Muscat, Sultanate of Oman
⁵ Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak, Ipoh 30450, Malaysia
⁶ Faculty of Applied Science & Centre of Excellence for Biomaterials Engineering, AIMST University, Kedah, Bedong 08100, Malaysia
⁷ Centre for Virus and Vaccine Research & Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Selangor 47500, Malaysia
⁸ Faculty of Medicine, AIMST University, Kedah 08100, Malaysia
⁹ School of Pharmaceutical Sciences (LIT-Pharmacy), Lovely Professional University, Jalandhar 144411, India
¹⁰ Department of Pharmacy, SMAS, Galgotias University, Greater Noida 203201, India
¹¹ Department of Pharmaceutical Sciences, Gurukul Kangri, Haridwar, Uttarakhand 249404, India

Correspondence Address:
Neeraj Kumar Fuloria
Faculty of Pharmacy & Centre of Excellence for Biomaterials Engineering, AIMST University, Bedong 08100, Kedah
Malaysia
Shivkanya Fuloria
Faculty of Pharmacy & Centre of Excellence for Biomaterials Engineering, AIMST University, Bedong 08100, Kedah
Malaysia

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1995-7645.326253